Dr Rebecca Harper is a postdoctoral researcher in the Cardiac Cellular Systems laboratory at the Baker Heart and Diabetes Institute. She is currently using spatial transcriptomic technology to investigate pathological cardiac remodelling.

Rebecca completed her PhD studies at the University of Adelaide where she developed a proof-of-concept, genetically engineered cell therapy for pulmonary arterial hypertension (PAH), Following this, she completed 2 years of postdoctoral studies at Stanford University in the Rabinovitch Laboratory. She used single cell RNA sequencing to discover a pathogenic transcriptional profile of PAH monocytes, demonstrating that these cells are a potential therapeutic target. Following this, she was a Visiting Fellow at the National Institutes of Health where she developed a human skin wound model to examine the transcriptional regulation of blood vessels during wound healing using single cell RNA sequencing and spatial transcriptomics.